Impact of vaccination and testing levels on the COVID-19 waves
Journal of Allergy & Infectious Diseases · 2024
DOI: 10.46439/allergy.5.045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy & Infectious Diseases, 2024. Verfasst von Igor Nesteruk. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
Record numbers of new COVID-19 cases and deaths registered in Japan, Europe, and other countries in 2022 aroused questions about efficacy of vaccination and testing. The pandemic waves in Japan, Ukraine, USA, Hong Kong, mainland China, South Korea, the UK, New Zealand, Africa, and Europe in 2020, 2021, and 2022 will be compared. Influence of vaccination and testing levels will be investigated.
Methods
The smoothed daily numbers of new cases and deaths per capita, case fatality risks as the ratio of these characteristics and accumulated numbers of deaths and cases, the tests per case ratio, and the non-linear correlation were used.
Results
As in other countries, new severe waves of the COVID-19 pandemic occurred in Japan in 2022 despite of very high vaccination level. Non-linear correlation revealed, that the daily number of new cases drastically decreases with the increase of the tests per case ratio.
Discussion
Increasing the test per case ratio and application of quarantine restrictions for the entire population, including vaccinated people, can be recommended to reduce the negative consequences of epidemics.
Zitieren
APA
Nesteruk, I. (2024). Impact of vaccination and testing levels on the COVID-19 waves. Journal of Allergy & Infectious Diseases. https://doi.org/10.46439/allergy.5.045
Vancouver
Nesteruk I. Impact of vaccination and testing levels on the COVID-19 waves. Journal of Allergy & Infectious Diseases. 2024. doi:10.46439/allergy.5.045
BibTeX
@article{Nesteruk2024,
author = {Nesteruk, Igor},
title = {Impact of vaccination and testing levels on the COVID-19 waves},
journal = {Journal of Allergy & Infectious Diseases},
year = {2024},
doi = {10.46439/allergy.5.045}
}
EUVIMED